2.0
6 Sept 2022
Current employee, more than 1 year
Sydney
Recommend
CEO approval
Business outlook
Pros
Staff on the ground are genuine and care about their patients
Cons
The company is owned by Primera venture capital and are focused on dollar value rather than patient outcome.